State Street’s Acorda Therapeutics ACOR Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q2 | – | Sell |
|
|||||
2023
Q1 | $18.5K | Hold |
|
|||||
2022
Q4 | $24.3K | Hold |
|
|||||
2022
Q3 | $9K | Hold |
|
|||||
2022
Q2 | $15K | Hold |
|
|||||
2022
Q1 | $51K | Hold |
|
|||||
2021
Q4 | $76K | Hold |
|
|||||
2021
Q3 | $146K | Hold |
|
|||||
2021
Q2 | $151K | Buy |
|
|||||
2021
Q1 | – | Sell |
|
|||||
2020
Q4 | $25K | Hold |
|
|||||
2020
Q3 | $19K | Hold |
|
|||||
2020
Q2 | $27K | Sell |
|
|||||
2020
Q1 | $1.39M | Buy |
|
|||||
2019
Q4 | $3M | Buy |
|
|||||
2019
Q3 | $4.06M | Sell |
|
|||||
2019
Q2 | $29.6M | Buy |
|
|||||
2019
Q1 | $44.3M | Buy |
|
|||||
2018
Q4 | $42M | Buy |
|
|||||
2018
Q3 | $52.6M | Buy |
|
|||||
2018
Q2 | $53.5M | Sell |
|
|||||
2018
Q1 | $59.1M | Buy |
|
|||||
2017
Q4 | $52.6M | Buy |
|
|||||
2017
Q3 | $51.7M | Sell |
|
|||||
2017
Q2 | $48.8M | Buy |
|
|||||
2017
Q1 | $34.1M | Sell |
|
|||||
2016
Q4 | $31M | Buy |
|
|||||
2016
Q3 | $31M | Buy |
|
|||||
2016
Q2 | $37.7M | Buy |
|
|||||
2016
Q1 | $38.5M | Buy |
|
|||||
2015
Q4 | $55.8M | Sell |
|
|||||
2015
Q3 | $40.9M | Sell |
|
|||||
2015
Q2 | $53.9M | Buy |
|
|||||
2015
Q1 | $46.8M | Buy |
|
|||||
2014
Q4 | $48.5M | Sell |
|
|||||
2014
Q3 | $43.4M | Sell |
|
|||||
2014
Q2 | $44.3M | Sell |
|
|||||
2014
Q1 | $52.7M | Sell |
|
|||||
2013
Q4 | $40.8M | Sell |
|
|||||
2013
Q3 | $50.2M | Buy |
|
|||||
2013
Q2 | $46.7M | Buy |
|